Regentis Biomaterials Ltd. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Regentis Biomaterials Ltd. (RGNT) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 678.36 thousand shares for the 12-month period ending 2025-12-31, per its 20-F/A filed 2026-02-27.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-02-27
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|
| 2025-12-31 | 678.36K shares 20-F/A · filed 2026-02-27 |
| 2024-12-31 | 246.66K shares 20-F/A · filed 2026-02-27 |
| 2023-12-31 | 246.66K shares 20-F/A · filed 2026-02-27 |